Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Science 37 Holdings Inc SNCE

Financial Services Technology Scientific & Technical Instruments
Science 37 Holdings, Inc. is engaged in patient-centric clinical trials and in supporting novel approaches to decentralized clinical trial designs. Through its patient-centric approach, it reduces the impact of the geographic barriers associated with conventional physical clinical trial sites, enabling recruitment of virtually any patient. Its offerings lie in its configurable unified... see more

Recent & Breaking News (NDAQ:SNCE)

Science 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire June 9, 2023

Science 37 Wins 2023 MedTech Breakthrough Award for "Best Overall Clinical Trial Platform"

GlobeNewswire May 18, 2023

Science 37 Reports First Quarter 2023 Financial Results

GlobeNewswire May 15, 2023

Science 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire May 5, 2023

Science 37 Joins Partnership in Support of White House CancerX and Cancer Moonshot

GlobeNewswire May 2, 2023

Science 37 to Report First Quarter 2023 Financial Results on May 15, 2023

GlobeNewswire May 1, 2023

Science 37 Appoints SVP, Erica Prowisor, to Bolster Patient Recruitment Velocity, Diversity

GlobeNewswire April 25, 2023

Science 37 Collaborates with AWS to Enable Faster, Patient-Friendly, Clinical Research

GlobeNewswire April 20, 2023

Science 37 Adds New Head of Quality, Irena Lambridis

GlobeNewswire April 18, 2023

Science 37 to Host Business Update Call on April 12, 2023

GlobeNewswire April 11, 2023

Science 37 Unveils Three Global Centers of Excellence to Drive Efficiency, Speed and Quality

GlobeNewswire April 11, 2023

Science 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire April 10, 2023

Science 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire March 10, 2023

Science 37 Reports Fourth Quarter and Full Year 2022 Financial Results

GlobeNewswire March 6, 2023

Science 37 to Present at the Cowen 43rd Annual Health Care Conference

GlobeNewswire February 23, 2023

Science 37 to Report Fourth Quarter 2022 Financial Results on March 6, 2023

GlobeNewswire February 21, 2023

Science 37 Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire February 10, 2023

Science 37 Acquires Vault Health's Life Sciences Platform To Bolster its Metasite Capabilities

GlobeNewswire February 2, 2023

Science 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire January 6, 2023

Science 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire December 9, 2022